GW Pharmaceuticals' Epidiolex Wins New FDA Approvals

GW Pharmaceuticals' (NASDAQ:GWPH) cannabidiol (CBD) drug Epidiolex has been granted Food and Drug Administration approval for a new indication. Additionally, its previous approval has been expanded to cover a wider age range of patients.